
Tomas Olsson
Articles
-
May 19, 2024 |
unt.se | Tomas Olsson
Lokalt Visa alla orter Uppsala Östhammar Tierp Knivsta Heby Älvkarleby Sigtuna Enköping Håbo Nyheter Senaste nytt Blåljus Ekonomi Valkompassen Sport Visa all sport Livesport Senaste nytt Sirius Fotboll Uppsala Fotboll Gusk Dalkurd Almtuna IS Sirius Bandy Storvreta IBK Sirius IBK Hagunda Uppsala Basket SSL Resultat Familj Familjenyheter Se dödsannonser (Till minne) Se familjeannonser Se köp och sälj Skicka in minnesord Skicka in familjeannonser Skicka in Dagens ros Åsikter Alla åsikter Ledare...
-
Mar 5, 2024 |
onlinelibrary.wiley.com | Jing Wu |Stockholm Sweden |Tomas Olsson |Lars Alfredsson
BACKGROUND Multiple sclerosis (MS) is a complex inflammatory and neurodegenerative disorder of the central nervous system, and its occurrence is positively associated with increasing latitude [1]. Insufficient sun exposure and vitamin D deficiency have consistently been associated with an increased risk of the disease [2, 3]. Higher latitude has also been associated with more severe disease [4, 5].
-
Jun 27, 2023 |
journals.sagepub.com | Lars Alfredsson |Tomas Olsson |Anna Karin Hedström
AbstractObjective:There is some evidence implicating diet in the development of inflammatory diseases. We aimed to study the influence of dietary habits on the risk of developing multiple sclerosis (MS). Methods:We used a population-based case–control study recruiting incident cases of MS (1953 cases, 3557 controls).
-
Apr 13, 2023 |
jnnp.bmj.com | Kelsi A Smith |Fredrik Piehl |Tomas Olsson |Lars Alfredsson
DiscussionTo the best of our knowledge, this is the first study consisting of a real-world MS population followed for a period of 10 years capturing routine clinical practice in treating spasticity among both incident and prevalent patients with MS. Baclofen remains the first-line option for managing spasticity in MS, and patterns of initiation and discontinuation described in this study are relevant to inform future clinical practice.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →